0000899243-23-015447.txt : 20230613
0000899243-23-015447.hdr.sgml : 20230613
20230613163018
ACCESSION NUMBER: 0000899243-23-015447
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230609
FILED AS OF DATE: 20230613
DATE AS OF CHANGE: 20230613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bonita David P
CENTRAL INDEX KEY: 0001572451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40287
FILM NUMBER: 231011572
MAIL ADDRESS:
STREET 1: C/O ORBIMED ADVISORS LLC
STREET 2: 601 LEXINGTON AVENUE, 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ikena Oncology, Inc.
CENTRAL INDEX KEY: 0001835579
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVE.
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 857-343-8292
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVE.
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-09
0
0001835579
Ikena Oncology, Inc.
IKNA
0001572451
Bonita David P
C/O IKENA ONCOLOGY, INC.
645 SUMMER STREET, SUITE 101
BOSTON
MA
02210
1
0
0
0
0
Stock Option (Right to Buy)
6.51
2023-06-09
4
A
0
17520
0.00
A
2033-06-09
Common Stock
17520
17520
D
This option shall vest in full upon the earlier of (i) June 9, 2024 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director.
/s/ Mark Manfredi, as Attorney-in-Fact for David P. Bonita
2023-06-13